Research Methodology – Anti-obesity Medication Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Anti-obesity Medication Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Anti-obesity Medication Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Number of prescription of anti-obesity drugs
- Prevalence and incidence rates of obesity in different regions
- Market penetration rates of different anti-obesity drugs
- Estimated population adhering to anti-obesity therapy
- Size of the global pharmaceutical industry
- Total health care expenditure on obesity globally
- Market shares held by the leading anti-obesity drug manufacturers
- The proportion of obese individuals seeking medication treatment
- Price and yearly cost of major prescription medications for obesity
Key Market Indicators
- Growth rate of obesity worldwide and comparison across countries/regions
- Number of new product launches/approvals for anti-obesity medications
- Shift towards sedentary lifestyle and unhealthy eating habits
- Changes in lifestyle and prevalence of diseases like diabetes, cardiovascular diseases, etc.
- Policy measures by health organizations/governments to combat obesity
- Demand for over the counter and prescription anti-obesity drugs
- Pipeline analysis of upcoming anti-obesity drugs
Growth Trends
- Increasing consumption of obesity related drugs due to growing awareness
- Growth in research and development activities in anti-obesity drugs
- Increasing rates of bariatric surgeries propelling the demand for anti-obesity drugs
- Rising adoption of unhealthy lifestyles leading to obesity
- Increased demand for personalized/precision medicine in obesity treatment
- Funding in research to develop novel obesity drugs
- Increasing collaborations between pharmaceutical companies in the obesity drug market
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Anti-obesity Medication Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Anti-obesity Medication Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
